COVID-19 INFO #2: HCP Respondent Response

As the COVID-19 situation develops we want to keep our clients and community updated on the...

Coronavirus: The Evolution of its Many Names

AplusA utilized social media analysis tools to observe the evolution of the use of the different...

COVID-19 INFO #1: Data Collection

AplusA teams have been receiving questions regarding the impact of COVID-19 on market research...

COVID-19 Message of Thanks to AplusA Healthcare Professional Study Participants

Doctor Christine Maï, AplusA Executive Vice-President, sent the following message to the...

AplusA COVID-19 Business Continuity Plan

In light of the current global COVID-19 outbreak, we wanted to share key points from AplusA's...

DLBCL Case Study: Enhancing Patient Journey Research with Social Media Listening

Using the example of a recent AplusA study in Diffuse Large B-Cell Lymphoma (DLBCL), we consider...

Patient Insights from AplusA’s Multiple Myeloma Tracker

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Multiple Myeloma Market Dynamics Revealed by AplusA Tracker

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Brand Performance Insights from AplusA's Multiple Myeloma Tracker

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Key Insights from a Multiple Myeloma Tracker

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...